Related Experiment Videos
[Malignant gliomas. Oncogenic considerations]
L Pérez-Ortiz1, T Zaldívar-Vaillant, J D Tamayo-Suárez
1Instituto de Neurología y Neurocirugía, Ciudad de La Habana, Cuba. David@uci.mtz.sld.cu
Revista De Neurologia
|August 19, 2000
Summary
Cancer arises from accumulated genetic changes, leading to uncontrolled cell growth. This review details molecular alterations in astrocyte gliomas, focusing on genetic pathways driving glioblastoma multiform development.
Area of Science:
- Neuro-oncology
- Cancer Genetics
Context:
- Cancer results from accumulated genetic alterations.
- Uncontrolled cell proliferation and loss of differentiation characterize cancer.
Purpose:
- To explain molecular alterations in anaplastic degeneration of astrocyte gliomas.
- To identify genetic pathways in glioblastoma multiform development.
Summary:
- Loss of genetic material on chromosomes 10 and 17, p53 gene mutation, and epidermal growth factor receptor amplification are key molecular alterations.
- Two genetic pathways lead to glioblastoma multiform: progressive degeneration of low-grade astrocytoma or de novo development from neuroglial cells.
- Translocations of chromosomes 9p, 13q, 19q, and 22q are also implicated.
Impact:
- Understanding oncogenes and tumor suppressor genes is crucial for controlling abnormal cell proliferation.
- Knowledge of these genetic changes will enable new therapeutic strategies for malignant astroglial neoplasias.